Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsight’s analysis, the market for age-related macular degeneration is ...

Older adults with diabetes who are using semaglutide are twice as likely to develop neovascular age-related macular ...

Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

Ocular Therapeutix showcases innovative retinal disease treatments at the Clinical Trials Summit 2025 in Las Vegas, featuring ...

Please ensure you refill your cup of coffee as we inform you about how to claim up to $5,300 before the deadline for this ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

So important for getting around, they had been in the care of an excellent pedicurist. However with more toe pain and ...

As we’re about to see, different food groups play different roles when it comes to eye health. The food groups we’re going to ...

Although GLP-1 drugs make headlines for vision risks, other weight-loss medications carry their own eye-related side effects.

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the ...

In this video, Peter K. Kaiser, MD, founding director of the Digital Eye Optical Coherence Tomography Reading Center at the Cole Eye Institute, discusses issues regarding delayed treatment for wet age ...

The US FDA has approved Ocugen’s IND amendment to commence a Phase II/III pivotal confirmatory study of OCU410ST.